March 3, 2008 - MicroDose TechnologiesInc. (MicroDose) announced that it has entered into a global license agreement with Merck & Co., Inc., through an affiliate, for use of MicroDose's proprietary dry powder inhaler (DPI) with Merck compounds. 
This agreement follows the successful completion of an exploratory study evaluating the MicroDose DPI technology.... [PDF]MicroDose Technologies' Press Release -
